We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

UCB Pharma Advances Next-Generation Antibody Discovery with Genedata Biologics

Leader in protein therapeutics development extends use of Genedata Biologics for next-generation antibody-based therapeutics R&D
News

RUB Researchers Clarify Catalysis Mechanism of Cell Growth Protein Ras

PNAS: proteins bring tension to the phosphate chain.
News

What's the Big Deal about Big Data?

The data-intensive nature of scientific research is currently driving the emergence of big data solutions that can gather, analyze, and transport extremely large volumes of data among multiple locations worldwide.
News

Genedata Screener Holds Global User Group Meetings for Innovations in Screening Data Analysis

Customers from leading pharmas including Roche and Sanofi will convene to discuss HTS, HCS, label-free, and Ion Channel data analysis
News

Mytrus and Its iPad® Application to Be Used in Clinical Study

Mobile Devices being deployed at 120 clinical test sites around the globe to speed enrollment and patient education during the informed consent process.
News

Thermo Fisher Scientific Updates Proteomics Analysis Software

Protein Metrics’ Byonic Search Software adds “ultimate search strategy” to Proteome Discoverer software version 2.0 to streamline post translational modification analysis.
News

New Web-Based App to Help Clinicians Improve Patient Care

PROOF Centre of Excellence & IO Informatics collaborate to bring precision medicine to the point of care.
News

FDA Approves New Orphan Drug for Chronic Myelogenous Leukemia

The U.S. Food and Drug Administration has approved Bosulif (bosutinib) to treat CML, a blood and bone marrow disease that usually affects older adults.
News

Study Points to New Target for Cancers Resistant to Certain Drugs

A more sensitive method to analyze protein interactions has uncovered a new way that cancer cells may use the cell-surface molecule HER3 to drive tumor progression following treatment with HER1 and HER2 inhibitors.
News

Protecting Genes, One Molecule at a Time

An international team of scientists have shown at an unprecedented level of detail how cells prioritise the repair of genes containing potentially dangerous damage.
Advertisement